Barbara J Schmid, Age 795439 Bryant St, Maple Plain, MN 55359

2007025, Nov 1, 2007

Apr 27, 2006

11/380548

James Reinke - Maple Grove MN, US
Jonathan Roberts - Coon Rapids MN, US
Glenn Roline - Anoka MN, US
Barbara Schmid - Forest Lake MN, US

A61N 1/16

607063000

According to the invention, a possible fault scenario involves an insulation breach of a medical lead which couples signals and/or electrical energy between a sensor and a circuit-bearing, active implantable medical device (AIMD). An initial response involves disconnecting the power source from the sensor with subsequent responses including selective reconnection of the power source. If the fault spontaneously resolves, then power to the sensor can be restored and physiologic signals transmitted to operative circuitry of the AIMD. In addition, however, an intermediate mode is enabled with the power source only coupled temporarily, for example, during intervals when stimulation and/or capture of excitable tissue (e.g., myocardial tissue) is not likely to occur due to any electrical shunt current(s). Thus, applying energy to a sensor(s) during the refractory period of a cardiac chamber eliminates undesired tissue activation. Moreover, sensed physiologic parameters can be collected without interrupting therapy delivery

5755742, May 26, 1998

Nov 5, 1996

8/741757

Robert J. Schuelke - Lakeville MN
Barbara J. Schmid - Minneapolis MN
Jonathan R. Gering - St. Louis Park MN

Medtronic, Inc. - Minneapolis MN

A61N 137

607 27

A lead integrity measurement system for a cardiac pacemaker/cardioverter/defibrillator (PCD) of the type comprising an implantable pulse generator (IPG) and a lead system including one or more pacing leads each having a proximal end coupled to a pacing terminal of the IPG and a distal end with at least one pace/sense electrode in contact with a patient's heart and a pair of defibrillation leads coupled to defibrillation terminals of the IPG and defibrillation electrodes implanted in relation to the patient's heart. In a lead impedance test mode, the terminal of a selected defibrillation lead under test is coupled to system ground, and an excitation voltage is applied in an excitation path from a force lead terminal selected from the pacing leads. A measure lead is selected from among the other of the pacing leads and defibrillation leads, and the voltage induced in the lead under test is measured through the measure lead and the electrode/tissue interface of the measure lead and the defibrillation lead under test. The applied current in the excitation path is also measured, and an impedance value is derived from the measured current and voltage values.

2020038, Dec 10, 2020

Aug 24, 2020

17/001424

- Minneapolis MN, US
Xusheng ZHANG - Shoreview MN, US
Vinod SHARMA - Maple Grove MN, US
James D. REINKE - Maple Grove MN, US
Barbara J. SCHMID - Forest Lake MN, US

A61B 5/0464
A61N 1/372
A61N 1/375
A61N 1/39
A61N 1/362
A61B 5/04
A61B 5/00

An implantable medical device comprises a sensing module configured to obtain electrical signals from one or more electrodes and a control module configured to process the electrical signals from the sensing module in accordance with a tachyarrhythmia detection algorithm to monitor for a tachyarrhythmia. The control module detects initiation of a pacing train delivered by a second implantable medical device, determines a type of the detected pacing train, and modifies the tachyarrhythmia detection algorithm based on the type of the detected pacing train.

2018008, Mar 29, 2018

Nov 15, 2017

15/813189

- Minneapolis MN, US
James K. CARNEY - Roseville MN, US
James D. REINKE - Maple Grove MN, US
Jon D. SCHELL - Shoreview MN, US
Barbara J. SCHMID - Forest Lake MN, US

A61N 1/362
A61N 1/375
A61N 1/39
A61N 1/372

An implantable medical device comprising a signal generator configured to generate and deliver anti-tachyarrhythmia pacing (ATP) to a heart of a patient and processing circuitry. The processing circuitry is configured to detect an enable event, responsive to detecting the enable event, enable the delivery of ATP by the signal generator, detect a disable event indicating that another implantable medical device cannot be relied upon to deliver an anti-tachyarrhythmia shock, and responsive to detecting the disable event, disable delivery of ATP.

2017031, Nov 2, 2017

Apr 29, 2016

15/143038

- Minneapolis MN, US
James K. Carney - Falcon Heights MN, US
James D. Reinke - Maple Grove MN, US
Jon D. Schell - Shoreview MN, US
Barbara J. Schmid - Forest Lake MN, US

A61N 1/362
A61N 1/39
A61N 1/375
A61N 1/39
A61N 1/372

An implantable medical device comprising a signal generator configured to generate and deliver anti-tachyarrhythmia pacing (ATP) to a heart of a patient and processing circuitry. The processing circuitry is configured to detect an enable event, responsive to detecting the enable event, enable the delivery of ATP by the signal generator, detect a disable event indicating that another implantable medical device cannot be relied upon to deliver an anti-tachyarrhythmia shock, and responsive to detecting the disable event, disable delivery of ATP.

2015030, Oct 29, 2015

Apr 15, 2015

14/687010

- Minneapolis MN, US
Xusheng ZHANG - Shoreview MN, US
Vinod SHARMA - Maple Grove MN, US
James D. REINKE - Maple Grove MN, US
Barbara J. SCHMID - Forest Lake MN, US

A61B 5/0464
A61B 5/04
A61B 5/00

An implantable medical device comprises a sensing module configured to obtain electrical signals from one or more electrodes and a control module configured to process the electrical signals from the sensing module in accordance with a tachyarrhythmia detection algorithm to monitor for a tachyarrhythmia. The control module detects initiation of a pacing train delivered by a second implantable medical device, determines a type of the detected pacing train, and modifies the tachyarrhythmia detection algorithm based on the type of the detected pacing train.